Clinical Trials Logo

Wounds and Injuries clinical trials

View clinical trials related to Wounds and Injuries.

Filter by:

NCT ID: NCT05407948 Completed - Stroke Clinical Trials

The Effect of Cognitive Reserve on Outcome After Stroke or Traumatic Brain Injury

Start date: November 2, 2018
Phase:
Study type: Observational

A long-term follow-up study of patients who acquired a stroke or traumatic brain injury (TBI) 5-15 years ago. Primary objective is to describe the interaction between measures of cognitive reserve and neuropsychological variables, psychological variables and healthcare usage in relation to outcome (i.e work return, satisfaction with life, psychological well-being and overall outcome) after stroke or traumatic brain injury. Secondary objectives are to describe differences in fatigue related to cognitive reserve after stroke or TBI and to describe differences in health-care usage related to cognitive reserve after stroke or TBI.

NCT ID: NCT05404425 Completed - Clinical trials for Pre-hospital Dispatching

Non-severe Traumatic Injuries Evaluation Using smartPhone Camera for Extra-hospital Regulation

NIEPCE
Start date: July 8, 2022
Phase: N/A
Study type: Interventional

Photography teletransmission allow a better and optimized dispatching of patients calling an Emergency Medical Call Center (EMCC) for a mild traumatic injury. It has previously been studied for patients to whom an ambulance was sent and therefore presumed to be older or with co-morbidities. The present trial aim to evaluate in the general population, the effect of a smartphone-mediated visioconference in the dispatching of patients calling an EMCC for mild traumatic injury.

NCT ID: NCT05398913 Completed - Clinical trials for Spinal Cord Injuries

Effects of Rimonabant on Walking Abilities in Incomplete Spinal Cord Injury

RIMOFATSCI-1
Start date: May 12, 2021
Phase: Phase 1/Phase 2
Study type: Interventional

Randomized placebo-controlled safety and feasibility study with crossover design (3 arms). Placebo or Rimonabant 2.5mg or Rimonabant 5mg will be administered for 5 days. Exploratory efficacy will be tested using six-min walking test.

NCT ID: NCT05391087 Completed - Clinical trials for Perioperative/Postoperative Complications

Comparison Arterial Blood Pressure and Cardiac Index-based Hemodynamic Management on Postoperative Myocardial Injury

Start date: June 1, 2022
Phase: N/A
Study type: Interventional

The primary aim of this study is to compare mean arterial pressure (MAP) and cardiac index (CI) based intraoperative hemodynamic management in terms of postoperative high sensitive troponin elevation. The hypothesis of the study is that there will be at least 5ng/L difference between the two groups in terms of troponin elevation occurring in the postoperative period. When power analysis was performed with this primary output, it was calculated that while alpha was 0.05 beta 0.2, 42 patients in each group, a total of 84 patients were required.

NCT ID: NCT05390281 Completed - Acute Kidney Injury Clinical Trials

Preoperative Level of Hemoglobin A1c and Acute Kindey Injury After Coronary Artery Bypass Grafting Surgery

Start date: June 1, 2019
Phase:
Study type: Observational

Background: The development of acute kidney injury (AKI) is an important indicator of clinical outcomes after cardiac surgery. Elevated preoperative hemoglobin A1c level may be associated with acute kidney injury in patients undergoing coronary artery bypass grafting. This study will investigate the association of preoperative HbA1c levels with AKI after isolated coronary artery bypass grafting (CABG).

NCT ID: NCT05387811 Completed - Acute Kidney Injury Clinical Trials

International Registry of Acute Kidney Injury in Cirrhosis: The GLOBAL AKI Project

GLOBAL-AKI
Start date: July 1, 2022
Phase:
Study type: Observational [Patient Registry]

The aims of this study will be to identify the clinical characteristics, the management and the outcomes of acute kidney injury in patients with cirrhosis worldwide. Specific aims: 1. To establish the severity of AKI across different regions 2. To identify precipitants of AKI across different centers 3. To identify the phenotypes of AKI across different centers 4. To evaluate differences in the management of AKI across different centers and their impact on clinical outcomes 5. To assess outcomes of acute kidney injury (resolution of AKI, in-hospital mortality, 28-day mortality, 90-day mortality)

NCT ID: NCT05381493 Completed - Acute Kidney Injury Clinical Trials

Incidence and Outcomes of Acute Kidney Injury in Trauma Patients Admitted to Critical Care

Start date: January 1, 2021
Phase:
Study type: Observational

Acute kidney injury (AKI) is a common complication that increases lenght of stay and mortality in trauma patients admitted to the intensive care unit (ICU). The aim of this study is to identify the incidence and outcomes of trauma patients, defined by Kidney Disease Improving Global Outcomes (KDIGO) criteria, at single center level 3 ICU.

NCT ID: NCT05378997 Completed - Clinical trials for Epidermolysis Bullosa

Safety, Tolerability, and Pharmacokinetics of Ascending Topical Doses of TCP-25 Applied to Epidermal Suction Blister Wounds, Non-Healing Leg Ulcers and Patients With Dystrophic Epidermolysis Bullosa.

Start date: April 7, 2022
Phase: Phase 1
Study type: Interventional

This is a three-part, Phase I, first-in-human study designed to evaluate the safety, tolerability, and potential systemic exposure of multiple topical doses of TCP-25. Part I includes healthy volunteers with acute epidermal wounds formed by the suction blister technique. Part II includes patients with non-healing leg ulcers and Part III patients with dystrophic epidermolysis bullosa (DEB).

NCT ID: NCT05376462 Completed - Trauma Clinical Trials

Quantra® System With the QStat® Cartridge in Trauma

Start date: April 12, 2022
Phase: N/A
Study type: Interventional

This is a prospective, single-center, controlled, open label, trial randomized in two parallel groups designed to assess the Quantra QStat System in trauma patients.

NCT ID: NCT05358470 Completed - Clinical trials for Acquired Brain Injury

Exercise Therapy Program on Acquired Brain Injury

Start date: February 1, 2023
Phase: N/A
Study type: Interventional

In this study, the physical and psychosocial effects of a exercise therapy and adapted physical activity program based on racket sports for ambulant people with acquired brain injury will be investigated.